通过重新激活免疫突触分子来增强抗瘤免疫力
Xindi Zhou1, Tian Xu2, Changhe Li1
1State Key Laboratory of Molecular Oncology, School of Basic Medical Sciences, Tsinghua University, Beijing 100084, China.
Cell reports. Medicine
|February 25, 2025
概括
瘤中ICAM-1的低表达阻碍了免疫突触的形成,导致对癌症免疫疗法的耐药性. 使用新型疗法恢复LFA-1信号克服了这一问题,增强了抗瘤免疫力,并与检查点封锁协同作用.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 免疫突触 (ISs) 对T细胞介导的瘤消除至关重要.
- 在免疫逃避和抵抗免疫检查点阻塞 (ICBs) 中ISs的作用尚未完全被理解.
- 在许多癌症中观察到ICAM-1的低表达,这是一个关键的IS分子.
研究的目的:
- 研究ICAM-1在抗瘤免疫和ICB耐药性中的作用.
- 阐明癌症中ICAM-1表达的调节机制.
- 开发新的治疗策略,以克服ICAM-1介导的免疫抵抗.
主要方法:
- 通过CRISPR查,确定ICAM-1的调节者.
- 对DNA甲基化通路的表观遗传学分析 (UHRF1,DNMT1).
- 基于抗体的治疗剂 ("LFA-1引入器") 的工程.
主要成果:
- 缺少ICAM-1赋予了对T细胞和NK细胞介导的抗瘤免疫的抵抗力.
- ICAM-1表达通过通过UHRF1和DNMT1.1通过DNA甲基化进行表观遗传调节.
- 在临床前模型中,LFA-1诱导剂恢复了LFA-1信号,增强了抗瘤细胞毒性,并与ICB协同作用.
结论:
- 降低ICAM-1调节是癌症中免疫逃避的一种机制.
- 针对ICAM-1的表观遗传调节和恢复LFA-1信号是有希望的治疗策略.
- 参与LFA-1的药物提供了一种新的方法来增强癌症免疫疗法,特别是在ICAM-1缺乏的瘤中.
更多相关视频
07:44Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.4K
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.1K
相关概念视频
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Cytotoxic T Cells-mediated Immune Response
826
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
826
T Cell Activation and Clonal Selection
625
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
625
